Peter Lu, Partner and Global Head of the China Practice at McDermott Will & Emery, discusses China’s opening of its health industry to international investors.
The idea is still at an early stage, but initial clinical study results show that immunotherapy against type 1 diabetes could function as a 'diabetes vaccine.'
There are 21 epilepsy-related deaths every week in the UK - here, Maxine Smeaton, Chief Executive of Epilepsy Research UK discusses what the future holds for essential epilepsy treatment research.
Scientists at the University of Nottingham are exploring the potential of new treatment for epilepsy, as they reveal that neuron connections in the brain can be a good indicator of disease progression.
Sarah-Jane McQueen, General Manager of the online healthcare course comparison website at CoursesOnline explains how health workers can find the time to focus on their learning & development in this special skills focus.
European Commission Director General for Health and Food Safety Sandra Gallina details the ambitious EU4Health Programme proposed as a response to COVID-19.
European Public Health Association Executive Director, Dineke Zeegers Paget, updates us about COVID-19 and its impact on society, public health, healthcare and equitable access to vaccines.
Assistant Professor Rachel Brulé, Global Development Policy at Boston University, says that COVID exposed existing inequalities and explains why gender inclusive institutions can help.
According to a new analysis by researchers, ethnic minorities in the US experienced disproportionately high levels of cardiac deaths during the pandemic - in comparison to the rates in 2019.
The team examined a mix of factors such as pollution, crime, access to education and healthcare - they found that in over 7,000 children, these factors directly impacted brain development.
The REACT study suggests that scientists don't know if the Indian variant is more infectious than the Kent variant - largely responsible for the winter wave of deaths.
